Searchable abstracts of presentations at key conferences in endocrinology

ea0081p586 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Weight loss variability with SGLT2 inhibitors, GLP-1 receptor agonists and repetitive Transcranial Magnetic Stimulation in Type 2 Diabetes and Obesity: results of a retrospective, comparative study

Ferrulli Anna , Massarini Stefano , Cannavaro Daniele , Perilli Paolo , Terruzzi Ileana , Senesi Pamela , Luzi Livio

Weight loss in individuals with Obesity (O) and Type 2 Diabetes (T2D), may improve glycaemic control and weight-related comorbidities, and in some cases, induce diabetes remission. However, body weight control is generally an unmet aim in this population. Thus, there is an increasing need to consider pharmacological approaches to assist weight loss in diabetes-obesity. Glucose-lowering agents as the sodium-glucose co-Transporter 2 inhibitors (SGLT2i) and GLP-1 Receptor Agonist...

ea0073aep651 | Thyroid | ECE2021

Evolution of SARS-CoV-2 related atypical thyroiditis

Muller Ilaria , Re Tiziana , Varallo Matteo , Daturi Anita , Cannavaro Daniele , Nadiani Benedetta , Dazzi Davide , Longari Virgilio , Cuzzocrea Marco , Gori Andrea , Mantovani Giovanna , Arosio Maura , Salvi Mario

BackgroundWe provided the first description of thyrotoxicosis due to atypical thyroiditis in patients hospitalised for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic disease (Covid-19), not associated with neck pain, more common in men, correlated with disease severity and coexisting with non-thyroidal illness syndrome. Classic viral subacute thyroiditis is often followed by permanent thyroid dysfunction and autoimmunity, thus we h...